Article
CXCR1+ neutrophil infiltration orchestrates response to third-generation EGFR-TKI in EGFR mutant non-small-cell lung cancer.
Signal transduction and targeted therapy - 6 Dec 2024
Wang Haowei, Xiong Anwen, Chen Xiaoxia, Guo Junhong, Tang Zhuoran, Wu Chunyan, Ren Shengxiang, Zhou Caicun, Chen Jian, Hou Likun, Jiang Tao
Abstract excerpt
Although third-generation Epidermal growth factor receptor-tyrosine kinase inhibitors (EGFR-TKI) is standard of care for patients with EGFR-mutant Non-small cell lung cancer (NSCLC), little is known about the predictors of response or resistance. Here, we integrated single-cell RNA (scRNA) sequencing, bulk RNA sequencing, multiplexed immunofluorescence and flow cytometry data from pretreatment and post-resistant...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
